Successful induction treatment of bullous pemphigoid using reslizumab: a case report
Abstract Background Bullous pemphigoid (BP) is a potentially life-threatening autoimmune blistering disease which is characterized by autoantibodies against hemidesmosomal proteins of the skin and mucous membranes. In recent years, the role of eosinophil and immunoglobulin E autoantibodies have been...
Guardado en:
Autores principales: | Hyo-In Rhyou, Song-Hee Han, Young-Hee Nam |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d3f44656035f48288734056531971335 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Commentary: Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
por: Si-Hang Wang, et al.
Publicado: (2021) -
Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment
por: Vito Di Lernia, et al.
Publicado: (2020) -
Bullous pemphigoid induced by Hijama therapy (cupping)
por: Arghavan Azizpour, et al.
Publicado: (2018) -
Diminished Expression of Galectin-3 Around Blisters in Bullous Pemphigoid: An Immunohistochemistry Study
por: Maryam Aghighi, et al.
Publicado: (2020) -
Case Report: Infantile Bullous Pemphigoid: Triggering by COVID-19 Is Speculative
por: Anna Rosińska-Więckowicz, et al.
Publicado: (2021)